Asthma control and quality of life in school aged children in Enugu, South East Nigeria

Ayuk, Adaeze; Oguonu, Tagbo; Ikefuna, AN; Ibe, BC

doi:10.1016/s1526-0542(12)70050-7

Cited by 14 publications

(27 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ayuk et al evaluated 90 children and adolescents with asthma in Nigeria and also found lower values for the PAQLQ symptoms domain in the adolescents 14-17 years of age; they concluded that older age was a strong predictor of poor quality of life in their study population. 33 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of quality of life according to asthma control and asthma severity in children and adolescents

et al. 2015

View full text Add to dashboard Cite

OBJECTIVE: To evaluate quality of life according to the level of asthma control and degree of asthma severity in children and adolescents. METHODS: We selected children and adolescents with asthma (7-17 years of age) from the Pediatric Pulmonology Outpatient Clinic of the State University of Campinas Hospital de Clínicas, located in the city of Campinas, Brazil. Asthma control and asthma severity were assessed by the Asthma Control Test and by the questionnaire based on the Global Initiative for Asthma, respectively. The patients also completed the Paediatric Asthma Quality of Life Questionnaire (PAQLQ), validated for use in Brazil, in order to evaluate their quality of life. RESULTS: The mean age of the patients was 11.22 ± 2.91 years, with a median of 11.20 (7.00-17.60) years. We selected 100 patients, of whom 27, 33, and 40 were classified as having controlled asthma (CA), partially controlled asthma (PCA), and uncontrolled asthma (UA), respectively. As for asthma severity, 34, 19, and 47 were classified as having mild asthma (MiA), moderate asthma (MoA), and severe asthma (SA), respectively. The CA and the PCA groups, when compared with the NCA group, showed higher values for the overall PAQLQ score and all PAQLQ domains (activity limitation, symptoms, and emotional function; p < 0.001 for all). The MiA group showed higher scores for all of the PAQLQ components than did the MoA and SA groups. CONCLUSIONS: Quality of life appears to be directly related to asthma control and asthma severity in children and adolescents, being better when asthma is well controlled and asthma severity is lower.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Our findings corroborate those of the study conducted in Turkey, whose authors found higher values in the MiA group than in the MoA group, as well as those of the study conducted in Nigeria, which also found the emotional function domain to be the least affected. 29 , 33 …”

Section: Discussionmentioning

confidence: 99%

Evaluation of quality of life according to asthma control and asthma severity in children and adolescents

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Ayuk et al showed that patients in this age group with a history of atopy had greater QOL impairment. 13 In the same way, Ozkaya et al also found that allergic rhinitis negatively affected the QOL in children. 19 These findings corroborate the results of the present study, suggesting that patients with allergic comorbidities have a more severe course of asthma due to their atopic nature, 12 and the severity of the disease is, in turn, related to the impact on QOL.…”

Section: Discussionmentioning

confidence: 87%

“…The literature provides different findings regarding which PAQLQ domain influences QOL the most. While some studies conducted in Turkey, Brazil, and Poland 6,11,12 revealed that the "activity limitation" domain has the lowest scores -and, therefore, greater impairment -, studies published in Nigeria, Portugal, and Egypt [13][14][15] indicate "symptoms" as the most affected domain.…”

Section: Discussionmentioning

confidence: 99%

Quality of Life Evaluation and Associated Factorsin Asthmatic Children and Adolescents Attended in a Specialized Outpatient Clinic

Fontan

Duwe

Santos

et al. 2020

Rev. paul. pediatr.

View full text Add to dashboard Cite

Objective: To evaluate the quality of life and its association with disease control, severity, allergic comorbidities and adherence to treatment in children and adolescents with asthma. Methods: A cross-sectional study that included children and adolescents aged seven to 17. The Paediatric Asthma Quality of Life Questionnaire (PAQLQ) was used to assess their quality of life. Sociodemographic and clinical data were obtained from the chart and from a questionnaire. Descriptive statistics were performed and chi-square or Fisher’s exact tests were used to verify the existence of associations between quality of life and disease control, severity, comorbidities and adherence to treatment. The level of statistical significance was set at p<0.05. Results: 101 children/adolescents were evaluated (62.4% boys), with a mean age of 10.1 years. On average, the PAQLQ score was ≤5.9 points, indicating moderate / severe quality of life impairment. Higher levels of control, as well as higher disease severity, were associated with higher quality of life impairment, both in total PAQLQ score and domains (p<0.05). The presence of comorbidities was also associated with higher quality of life impairment (p=0.01), except in the emotional function domain. Adherence to treatment showed no association with quality of life. Conclusions: Children and adolescents with asthma present impairment in their quality of life, and this is related to poorer control and severity of the disease, as well as to the presence of allergic comorbidities.

show abstract

“…Given that allergic disorders primarily affect children, this can be integrated into maternal and child health programs. Obeng et al, 2014;Stevens et al, 2011;AddoYobo et al, 2007, 2001, 1997, Hesse, 1995Hogewoning et al, 2012X Amoah et al, 2013Kenya Ait-Khaled et al, 2007Perzanowski et al, 2002;Ng'ang'a et al, 1998;Odhiambo et al, 1998;Ng'ang'a et al, 1997;Odhiambo et al, 1994;Odhiambo & Chwala, 1992;De Souza, 1992 a ; Gathua & Aluoch, 1990Esamai et al, 2002 a ;Esamai & Anabwani, 1996;De Souza, 1992Esamai et al, 2002;De Souza, 1992 De Souza, 1994 Lesotho X X X X Liberia X X X X Malawi X X X X Namibia X X X X Nigeria Ayuk et al, 2014...…”

Section: Discussionmentioning

confidence: 99%

The Global Epidemiologic Transition

Atiim

Elliott

2016

Health Educ Behav

View full text Add to dashboard Cite

Globally, there has been a shift in the causes of illness and death from infectious diseases to noncommunicable diseases. This changing pattern has been attributed to the effects of an (ongoing) epidemiologic transition. Although researchers have applied epidemiologic transition theory to questions of global health, there have been relatively few studies exploring its relevance especially in the context of emerging allergic disorders in sub-Saharan Africa (SSA). In this article, we address the growing burden of noncommunicable diseases in sub-Saharan Africa through the lens of epidemiologic transition theory. After a brief review of the literature on the evolution of the epidemiologic transition with a particular emphasis on sub-Saharan Africa, we discuss existing frameworks designed to help inform our understanding of changing health trends in the developing world. We subsequently propose a framework that privileges "place" as a key construct informing our understanding. In so doing, we use the example of allergic disease, one of the fastest growing chronic conditions in most parts of the world.

show abstract

Asthma control and quality of life in school aged children in Enugu, South East Nigeria

Cited by 14 publications

References 0 publications

Evaluation of quality of life according to asthma control and asthma severity in children and adolescents

Evaluation of quality of life according to asthma control and asthma severity in children and adolescents

Quality of Life Evaluation and Associated Factorsin Asthmatic Children and Adolescents Attended in a Specialized Outpatient Clinic

The Global Epidemiologic Transition

Contact Info

Product

Resources

About